Better Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Better Therapeutics

09/08/2023 22:02

* Better Therapeutics Inc  BTTX.OQ  reported a quarterly
adjusted
loss of 24 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 31 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Better Therapeutics Inc's reported EPS for the quarter was
a
loss of 24 cents​.
    * The mean earnings estimate of analysts had risen by
about 61.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Better Therapeutics Inc shares had fallen by 33.3% this
quarter and lost 34.8% so far this year.
    * The company reported a quarterly loss of $7.59 million.
    * Wall Street's median 12-month price target for Better
Therapeutics Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.31          -0.24          Beat
 Mar. 31 2023      -0.74          -0.39          Beat
 Dec. 31 2022      -0.51          -0.37          Beat
 Sep. 30 2022      -0.48          -0.48          Met